← Back to headlines
AbbVie Inc. Announces EC Authorization for Expanded VENCLYXTO® Label
AbbVie Inc. has announced that the European Commission has granted authorization for an expanded label for its drug VENCLYXTO®.
2 Jun, 14:42 — 2 Jun, 14:42
Sources
Showing 1 of 1 sources
Related Stories
Honda Orders $9 Billion Supplier Cost Cuts to Counter Chinese EV Rivals
34m ago
US-Iran Conflict Intensifies with Retaliatory Strikes and Rising Energy Prices
37m ago
Apple Appoints John Ternus as CEO Amid Leadership Transition and Strategic Shift
39m ago
Nestlé to Sell Vitamins Business to Financial Investor for $1 Billion
55m ago